September 24, 2020 by cttc_admin
Who developed the R.E.A.C.H.?
Lindsay Mayberry
Chandra Osborn
Lyndsay Nelson
Chad Gentry
Ken Wallston
Sunil Kripalani
How is this product/software different from other similar tools?
Most text messaging apps are event-centric (e.g. clinic reminders/rescheduling) and not patient-centric (tailored to patient data or preferences). REACH is patient-centric (i.e. tailored to patients' preferred time of day, daily routine, prescribed medications, barriers to adherence) and longitudi-nal, supporting re-tailoring over time as medication regimens and/or barriers change. REACH has al-so been shown to improve adherence for 12 months, have high user-engagement for 12 months, and to improve glycemic control among patients with elevated glycemia in a high-quality trial.
Is there a peer reviewed publication that describes the research related to this Manual?
"Improvement in Social Competence Using a Randomized Trial of a Theatre Intervention for Children with Autism Spectrum Disorder." Corbett et al., J Autism Dev Disord. 2015 Sep 29. http://www.ncbi.nlm.nih.gov/pubmed/26419766
Is there a peer reviewed publication that describes the product/software?
Nelson et al, JMIR Hum Factors 2016;3(2):e23
DOI:10.2196/humanfactors.6029
How does the product/software work?
The authors engaged the services of a digital health company (MemoText) to design an algorithm for deployment of the text content developed by the authors. The content and algorithms being li-censed can be used with the client’s choice of messaging platform.
What computer platforms/operating systems are recommended for this prod-uct/software to work?
MemoText or other messaging platforms of the client’s choice.
What additional software needs to be installed for proper working of this prod-uct/software?
The content is meant to be used with a text-based messaging platform.
- Login to post comments
